|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| License and other revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Change in fair value of contingent value rights | |||||
| Loss from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Loss on extinguishment of debt | |||||
| Other non-operating income (expense), net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive (loss) income: | |||||
| Foreign currency translation adjustments | |||||
| Unrealized gain on available for sale securities, net of taxes | |||||
| Unrealized gain on available for sale securities, net of tax of $0.1 million in 2025 and $0.8 million in 2024 | |||||
| Reclassification adjustment for realized net gain on available for sale marketable securities included in net loss, net of tax of $0.8 million in 2025 and $0.4 million in 2024 | |||||
| Other comprehensive (loss) income | |||||
| Total comprehensive (loss) income | |||||
| Net loss per ordinary share - basic (in dollars per share) | |||||
| Net loss per ordinary share - diluted (in dollars per share) | |||||
| Weighted average ordinary shares outstanding - basic (in shares) | |||||
| Weighted average ordinary shares outstanding - diluted (in shares) | |||||
Loading...
